Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges. Find out who is the winner.

Lowe's Companies, Inc. presents revenue growth potential for 2025, strong shareholder returns, and discounted valuation ...

Discover how new tariffs, overvalued stocks, and shrinking profit margins could impact S&P 500 earnings and signal potential ...

Workiva stock drops 30%, but with a $35B TAM and growing EU compliance demand, it remains a buy at <5x forward revenue. Click ...

The sweeping policy change for US tariffs announced yesterday by President Trump is a game changer for the global economy.

Good morning, everybody, and welcome to day two of the 11th Annual J.P. Morgan Retail Round Up Conference. Lots of news out last night. It's my pleasure to have EVP and CFO of the Home Depot, Richard ...

Village Super Market, Inc. stock shows strong earnings growth and potential. Click for my updated look at why VLGEA stock is ...

See how the 10 largest small-cap exchange traded funds from a market cap perspective are trading on Thursday while Wall ...

Esquire Financial Holdings has shown impressive growth, outperforming the S&P 500 by rising 63.8% since June 2024. Learn more ...

Most solar shares trade lower after President Trump unveiled sweeping tariffs on imports to the U.S., including heavy levies on countries that are major manufacturers of solar products.

Opendoor's business continues to be challenged by high-interest rates, housing market weakness, and macro uncertainty. Read ...

First Industrial Realty Trust excels with strong rent growth and a strategic U.S. market focus. Learn why FR stock remains a ...